ERBB2 and breast carcinoma: Breast cancer presents considerable heterogeneity and is classified according to its immunohistochemical profile as luminal A, luminal B, human epidermal growth factor receptor 2 (HER2-positive), triple-negative breast cancer (TNBC) or basal-like and recently discovered Claudin-low [3,4,5].